Buonfrate D, Requena-Mendez A, Angheben A, Munoz J, Gobbi F, Van Den Ende J, et al. Severe strongyloidiasis: a systematic review of case reports. BMC Infect Dis 2013;13:78. https://www.ncbi.nlm.nih.gov/pubmed/23394259
Chiodini PL, Reid AJ, Wiselka MJ, Firmin R, Foweraker J. Parenteral ivermectin in Strongyloides hyperinfection. Lancet 2000;355(9197):43–4. https://www.ncbi.nlm.nih.gov/pubmed/10615895
Grein JD, Mathisen GE, Donovan S, Fleckenstein L. Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: a case report. Scand J Infect Dis 2010;42(3):234–6. https://www.ncbi.nlm.nih.gov/pubmed/20085425
Gupta S, Jain A, Fanning TV, Couriel DR, Jimenez CA, Eapen GA. An unusual cause of alveolar hemorrhage post hematopoietic stem cell transplantation: a case report. BMC Cancer 2006;6:87. https://www.ncbi.nlm.nih.gov/pubmed/16603072
Hauber HP, Galle J, Chiodini PL, Rupp J, Birke R, Vollmer E, et al. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin. Infection 2005;33(5-6):383–6. https://www.ncbi.nlm.nih.gov/pubmed/16258873
Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC Jr., Terashima A, Samalvides F, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev 2016;(1):CD007745. https://www.ncbi.nlm.nih.gov/pubmed/26778150
Huston JM, Eachempati SR, Rodney JR, Cayci C, Fusco D, Mathew M, et al. Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient. Transpl Infect Dis 2009;11(3):277–80. https://www.ncbi.nlm.nih.gov/pubmed/19392733
Leung V, Al-Rawahi GN, Grant J, Fleckenstein L, Bowie W. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection. Am J Trop Med Hyg 2008;79(6):853–5. https://www.ncbi.nlm.nih.gov/pubmed/19052292
Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, et al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis 2005;41(1):e5–8. https://www.ncbi.nlm.nih.gov/pubmed/15937753
Pacanowski J, Santos MD, Roux A, LEM C, Guillot J, Lavarde V, et al. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 2005;73(1):122–4. https://www.ncbi.nlm.nih.gov/pubmed/16014846
Satou T, Koga M, Koike K, Tada I, Nikaido T. Nematocidal activities of thiabendazole and ivermectin against the larvae of Strongyloides ratti and S. venezuelensis. Vet Parasitol 2001;99(4):311–22. https://www.ncbi.nlm.nih.gov/pubmed/11511418
Turner SA, Maclean JD, Fleckenstein L, Greenaway C. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am J Trop Med Hyg 2005;73(5):911–4. https://www.ncbi.nlm.nih.gov/pubmed/16282302
